The evolution of COPD species; or, something is changing for good in COPD
- PMID: 31249010
- DOI: 10.1183/13993003.00762-2019
The evolution of COPD species; or, something is changing for good in COPD
Conflict of interest statement
Conflict of interest: J.B. Soriano participated in speaking activities, advisory committees and consultancies during the period 2014–2019 sponsored by: Almirall, AstraZeneca, Boehringer Ingelheim, CHEST, Chiesi, ERS, GEBRO, Grifols, GSK, Linde, Lipopharma, Mundipharma, Novartis, Pfizer, RiRL, Rovi, Sandoz, SEPAR and Takeda. J.B. Soriano declares not receiving ever, directly or indirectly, funding from the tobacco industry or its affiliates.
Comment on
-
Assessing global COPD awareness with Google Trends.Eur Respir J. 2019 Jun 27;53(6):1900351. doi: 10.1183/13993003.00351-2019. Print 2019 Jun. Eur Respir J. 2019. PMID: 31097517
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical